GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Interest Expense

Eckert & Ziegler SE (XTER:EUZ) Interest Expense : €-3.7 Mil (TTM As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Eckert & Ziegler SE's interest expense for the three months ended in Dec. 2024 was € -0.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-3.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Eckert & Ziegler SE's Operating Income for the three months ended in Dec. 2024 was € 20.5 Mil. Eckert & Ziegler SE's Interest Expense for the three months ended in Dec. 2024 was € -0.8 Mil. Eckert & Ziegler SE's Interest Coverage for the quarter that ended in Dec. 2024 was 26.09. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Eckert & Ziegler SE Interest Expense Historical Data

The historical data trend for Eckert & Ziegler SE's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Interest Expense Chart

Eckert & Ziegler SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.19 -1.20 -1.77 -3.99 -3.75

Eckert & Ziegler SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.17 -0.95 -1.09 -0.93 -0.78

Eckert & Ziegler SE Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eckert & Ziegler SE  (XTER:EUZ) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Eckert & Ziegler SE's Interest Expense for the three months ended in Dec. 2024 was €-0.8 Mil. Its Operating Income for the three months ended in Dec. 2024 was €20.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was €46.1 Mil.

Eckert & Ziegler SE's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*20.458/-0.784
=26.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Eckert & Ziegler SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Interest Expense
Comparable Companies
XTER:SBS XTER:AAQ1 XTER:GME ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE ZBH PODD XSWX:SOON SHSE:688271 TSE:7733 PEN TSE:6869
Traded in Other Exchanges
1EUZ:Italy EUZd:UK 0NZY:UK EUZG:Austria
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Website
https://www.ezag.com
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors

Eckert & Ziegler SE Headlines

No Headlines